title: Lipid-lowering drugs: who gets what?
authors.affiliation: University of Manchester Department of Medicine, Manchester Royal Infirmary, UK.
authors.forename: P N
authors.initials: PN
authors.lastname: Durrington
authors.forename: R
authors.initials: R
authors.lastname: Illingworth
mesh_terms: D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D006951:Hyperlipoproteinemias / Q000188:drug therapy; D015228:Hypertriglyceridemia / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D015994:Incidence; D008017:Life Expectancy; D008079:Lipoproteins, VLDL / Q000097:blood
chemical_list: D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D008079:Lipoproteins, VLDL